Middle East & Africa

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Middle East & Africa Analysis

Industry Trend Analysis - Algerian Insulin Agreement Highlights Biocon's Biologic Ambitions - OCT 2017

This collaboration complements Biocon's efforts to commercialise its biologic and biosimilar products in less well-regulated markets, but enhances Abdi Ibrahim's expansion aims also. Biocon's Biologic segment is still a small part of its business, but has grown quickly over the last few years. Launching its insulin product in Algeria will further boost sales, but its partnership with Mylan will...

READ FULL ARTICLE...

Industry Trend Analysis - A Recap On The Pharmaceuticals & Healthcare Outlook For 2017: Middle East & North Africa - SEPT 2017

The MENA region's pharmaceutical and healthcare markets will be shaped by a range of opportunities and challenges in 2017. Ongoing trends, such as the rollout of compulsory health insurance schemes, generic substitution and medical tourism are expected to continue shaping the pharmaceutical market. Challenges will intensify, however, and while discrepancies exist at the country level, growth is...

READ FULL ARTICLE...